MIG Fonds, managed by MIG Capital AG, is a Munich-based venture capital firm that invests in young deep tech and life sciences companies in German-speaking Europe and beyond. The firm has invested over €760 million in about 50 companies, focusing on sectors such as biopharmaceuticals, energy and environmental technologies, advanced computing, digitization/IoT, medical technology, and digital health. MIG's investment team comprises experts including engineers, biologists, scientists, and investors who evaluate business models and technologies to support the growth of their portfolio companies.
Is MIG Fonds the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with MIG Fonds, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
€1,000,000 - €10,000,000
When approaching MIG Fonds, founders should highlight the scientific rigor and technical depth of their solution, demonstrating clear differentiation and defensibility in both technology and IP. Emphasize robust validation data, regulatory pathways, and a credible plan for scaling within complex, regulated markets. MIG values teams with deep domain expertise and a track record of navigating technical and commercial milestones, so showcasing a multidisciplinary team and early traction with industry partners or customers can set you apart.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.